EDITOR’S MESSAGE
An integral part of the annual meeting of the American Academy of Ophthalmology has always been walking the exhibit hall floor to check out the new products and technologies that are available to help us as retina specialists improve patient care and practice. Retinal Physician has invited leading vendors to provide information about and insight into their new product offerings. In this year’s AAO Retina Product Pavilion, you will find a display of the latest technologies that companies have recently brought to market. A link is included for a deeper dive into these companies and product features. You will also be receiving an email of this Retina Product Pavilion feature with direct links to these vendor and product websites.
I am always amazed at the innovation and breakthroughs taking place in our field. Patient care usually begins with technology, and the following products are here to do just that — to help improve your patient outcomes and practice success. Thank you to our product vendors!
Peter K. Kaiser, MD
Editor in Chief
Find the product pavilion in the digital edition:
ALIMERA SCIENCES
Alimera is a global pharmaceutical company whose mission is to be invaluable to patients, physicians, and partners concerned with retinal health and maintaining better vision longer. To learn how our products can treat DME and NIU-PS with continuous microdosing for up to 36 months, come visit us at AAO booth #1814.
APELLIS PHARMACEUTICALS
Apellis is a global biopharmaceutical company that leverages courageous science and creativity. We are committed to addressing the unmet needs of patients and eyecare professionals worldwide.
AAO booth #5927
BAUSCH + LOMB
Bausch + Lomb is a global eye health organization with core businesses in over-the-counter products, dietary supplements, eyecare products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices, and instruments. Bausch + Lomb develops, manufactures, and markets one of the most comprehensive product portfolios in the industry.
AAO booth #205
ESIGHT
eSight – see new possibilities. Empower patients with eSight, the clinically validated, all-in-one solution for low-vision patients, proven to enhance vision. Extensive research and purpose-driven design sets eSight apart. From seeing faces, advancing in school or work, or resuming hobbies, eSight dramatically improves quality of life.
AAO booth #5831
IVERIC BIO, AN ASTELLAS COMPANY
Iveric Bio, an Astellas Company, is a science-driven biopharmaceutical company focused on the discovery and development of novel treatments for retinal diseases with significant unmet medical needs. The company is committed to having a positive impact on patients’ lives by delivering high-quality, safe, and effective treatments designed to address debilitating retinal diseases, including earlier stages of age-related macular degeneration. For more information on the company, please visit www.ivericbio.com .
AAO booth #7601
MEDONE SURGICAL, INC.
MedOne surgical and eye technology bring decades of experience to the ophthalmic surgeon with an extensive line of American-made, single-use cannula products for challenging retina cases, using 23-gauge, 25-gauge, and 27-gauge systems, as well as an extensive line of subretinal drug delivery devices. Additional offerings include our high-precision reusable instrumentation produced in the United Kingdom for all segments of ophthalmic surgical procedures.
AAO booth #5923
OPTOS
Optos ultrawidefield (UWF) optomap multimodality retinal imaging is the only true UWF imaging technology — documenting up to 82% of the retina in a single capture. Thousands of peer-reviewed studies confirm that optomap enables health care professionals to detect and manage retinal pathology more effectively. optomap is revolutionizing health care, helping professionals save sight and save lives.
AAO booth #5847
REGENERON
Regeneron is a leading biotechnology company that invents medicines for serious diseases. Founded and led for over 30 years by physician-scientists, our unique ability to repeatedly translate science into medicine has led to numerous FDA-approved treatments and product candidates in development. Visit www.regeneron.com to learn more.
AAO booth numbers #7309, #5832, and #715